Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.46 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Zhengye Biotechnology Holding (ZYBT) Non-Current Deferred Tax Liability (2025)

Updated

Zhengye Biotechnology Holding's Non-Current Deferred Tax Liability came in at $14,663 for the quarter ended Dec 31, 2025.

Analysis

Zhengye Biotechnology Holding (ZYBT) Non-Current Deferred Tax Liability (2025) Analysis & Trends

As of Dec 31, 2025, Zhengye Biotechnology Holding's Non-Current Deferred Tax Liability was $15,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Zhengye Biotechnology Holding 69.19 Mn 65.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 14,865.43
API Access

Zhengye Biotechnology Holding Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ZYBT&period=max&api_key=YOUR_API_KEY